Peripheral blood stem cell mobilization with pegylated granulocyte colony stimulating factor in children.

Cancer Rep (Hoboken)

Department of Pediatric Hematology Oncology and BMT, Medanta The Medicity, Gurgaon, India.

Published: December 2021

Background And Aim: We report here our experience of using pegylated granulocyte colony stimulating factor (peg-GCSF) for peripheral blood stem cell (PBSC) mobilization in children.

Methods And Results: A total of nine children suffering from high-risk/relapsed solid tumors were mobilized with chemotherapy and peg-GCSF (100 microgram/kg single dose). Mean age was 7.7 years (range 2-15 years).The mean time from peg-GCSF administration to PBSC harvest was 9.7 days. Adequate stem cells (median dose 26.9 million/kg) could be harvested in all children by a single apheresis procedure. No major adverse events observed.

Conclusion: It is feasible and safe to mobilize PBSC with peg-GCSF in children with cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714533PMC
http://dx.doi.org/10.1002/cnr2.1408DOI Listing

Publication Analysis

Top Keywords

peripheral blood
8
blood stem
8
stem cell
8
pegylated granulocyte
8
granulocyte colony
8
colony stimulating
8
stimulating factor
8
cell mobilization
4
mobilization pegylated
4
children
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!